TPG Capital acquires minority stake in Rodan + Fields

The number one skin care brand in the US sells dermatology-inspired products based around four regimens

Rodan + Fields, the number one skin care brand in the US, has sold a minority stake to private equity firm TPG Capital.

The acquisition is focused on accelerating the brand’s next phase of growth both domestically and internationally.

The brand’s founders Dr Katie Rodan and Dr Kathy Fields will continue to drive the brand, as will its senior leadership team.

Diane Dietz, CEO and President of Rodan + Fields, said: “TPG’s successful track record growing iconic brands and their belief in our disruptive model, innovative products, and powerful Independent Consultant Community make them an excellent partner.”

TPG Capital will support the dermatology-inspired brand by providing access to business building expertise and resources.

Jim Coulter, co-CEO and co-founder of TPG, and Paul Hackwell, TPG Capital Sector Lead for Consumer Investments, will join Rodan + Fields’ Board of Directors.

Coulter added: “As a firm with a history of investing in businesses that are fundamentally changing their industries, we see Rodan + Fields as being at the intersection of emerging consumer trends and technology disruptions.

“This is exactly the kind of partnership we look for – an outstanding brand with proven success, an experienced and talented management team, and significant runway for growth.”

Rodan + Fields is the fastest-growing brand in beauty and personal care in the US, according to Euromonitor International.

It offers consumers skin care products around four regimens: Redefine, Reverse, Unblemish and Soothe.